Bombay HC restrains firm from infringing Sun Pharma trademark Prolomet - Video

Published On 2021-10-28T14:00:37+05:30 | Updated On 6 Oct 2023 5:15 PM IST

Overview

The Bombay High Court has noted an ad-interim injunction restraining the Salud Care (India) Private from using trademark PROLOMEK or any other trademark that is identical with or deceptively or confusingly similar to Sun Pharma Laboratories Ltd's mark PROLOMET.

The order was issued during a hearing conducted by G S Patel through video conferencing, deliberating the case filed by Sun Pharma. The counsel for Sun Pharma informed the court that in April 2021, Sun Pharma learned that Salud Care (India) Private markets a pharmaceutical preparation for the treatment of hypertension with tachycardia, angina, hyperthyroidism, and myocardial infarction with the same based drug, Metoprolol Succinate, under the trade mark PROLOMEK.

For more details, check out the full story on the link below:

Bombay HC Restrains Firm From Infringing Sun Pharma Trademark Prolomet

Speakers

Roshni Dhar

Roshni Dhar, a Mass com graduate with a soft corner for health happenings, joined Medical Dialogues as a news anchor in 2021. Inspired by her mother who is a gynaecologist, she likes to keep herself and the world updated on the occurring in the medical field. She covers various aspects of health news for MDTV at Medical Dialogues. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751